These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


362 related items for PubMed ID: 18388801

  • 1. The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies.
    Racke MK.
    Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S9-S18. PubMed ID: 18388801
    [Abstract] [Full Text] [Related]

  • 2. B cells in spontaneous autoimmune diseases of the central nervous system.
    Berer K, Wekerle H, Krishnamoorthy G.
    Mol Immunol; 2011 Jun; 48(11):1332-7. PubMed ID: 21146219
    [Abstract] [Full Text] [Related]

  • 3. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH, Linker RA.
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [Abstract] [Full Text] [Related]

  • 4. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
    Stinissen P, Raus J.
    Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
    [Abstract] [Full Text] [Related]

  • 5. B cells and antibodies in MS.
    Reindl M, Kuenz B, Berger T.
    Results Probl Cell Differ; 2010 Mar; 51():99-113. PubMed ID: 19513636
    [Abstract] [Full Text] [Related]

  • 6. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
    Genain CP, Cannella B, Hauser SL, Raine CS.
    Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55.
    Ichikawa M, Johns TG, Liu J, Bernard CC.
    J Immunol; 1996 Jul 15; 157(2):919-26. PubMed ID: 8752946
    [Abstract] [Full Text] [Related]

  • 9. B cells and multiple sclerosis.
    Franciotta D, Salvetti M, Lolli F, Serafini B, Aloisi F.
    Lancet Neurol; 2008 Sep 15; 7(9):852-8. PubMed ID: 18703007
    [Abstract] [Full Text] [Related]

  • 10. B-cell-targeted treatment for multiple sclerosis: mechanism of action and clinical data.
    Hawker K.
    Curr Opin Neurol; 2008 Apr 15; 21 Suppl 1():S19-25. PubMed ID: 18388796
    [Abstract] [Full Text] [Related]

  • 11. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
    El Behi M, Dubucquoi S, Lefranc D, Zéphir H, De Seze J, Vermersch P, Prin L.
    Immunol Lett; 2005 Jan 15; 96(1):11-26. PubMed ID: 15585303
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. T-cells in multiple sclerosis.
    Severson C, Hafler DA.
    Results Probl Cell Differ; 2010 Jan 15; 51():75-98. PubMed ID: 19582415
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
    Cross AH, Stark JL.
    Immunol Res; 2005 Jan 15; 32(1-3):85-97. PubMed ID: 16106061
    [Abstract] [Full Text] [Related]

  • 16. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response.
    Stefferl A, Brehm U, Storch M, Lambracht-Washington D, Bourquin C, Wonigeit K, Lassmann H, Linington C.
    J Immunol; 1999 Jul 01; 163(1):40-9. PubMed ID: 10384097
    [Abstract] [Full Text] [Related]

  • 17. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S, Floßdorf J, Grützke B, Dunay IR, Frenzel K, Jungverdorben J, Linnartz B, Mack M, Peitz M, Brüstle O, Kurts C, Klockgether T, Neumann H, Prinz M, Wiendl H, Knolle P, Klotz L.
    Brain; 2012 May 01; 135(Pt 5):1586-605. PubMed ID: 22447120
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses.
    Huntington ND, Tomioka R, Clavarino C, Chow AM, Liñares D, Maña P, Rossjohn J, Cachero TG, Qian F, Kalled SL, Bernard CC, Reid HH.
    Int Immunol; 2006 Oct 01; 18(10):1473-85. PubMed ID: 16914508
    [Abstract] [Full Text] [Related]

  • 20. B- and T-cell responses in multiple sclerosis: novel approaches offer new insights.
    Hohlfeld R, Meinl E, Dornmair K.
    J Neurol Sci; 2008 Nov 15; 274(1-2):5-8. PubMed ID: 18707694
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.